Renaissance Technologies’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-254,768
| Closed | -$1.53M | – | 3596 |
|
|
2025
Q1 | $1.53M | Buy |
254,768
+11,839
| +5% | +$70.9K | ﹤0.01% | 2153 |
|
|
2024
Q4 | $1.89M | Buy |
+242,929
| New | +$1.89M | ﹤0.01% | 2090 |
|
|
2024
Q2 | – | Sell |
-299,668
| Closed | -$2.01M | – | 3552 |
|
|
2024
Q1 | $2.01M | Buy |
299,668
+273,400
| +1,041% | +$1.84M | ﹤0.01% | 2027 |
|
|
2023
Q4 | $154K | Buy |
+26,268
| New | +$154K | ﹤0.01% | 3207 |
|
|
2023
Q2 | – | Sell |
-61,468
| Closed | -$663K | – | 3965 |
|
|
2023
Q1 | $663K | Buy |
+61,468
| New | +$663K | ﹤0.01% | 2719 |
|
|
2022
Q4 | – | Sell |
-15,168
| Closed | -$226K | – | 4145 |
|
|
2022
Q3 | $226K | Sell |
15,168
-26,632
| -64% | -$397K | ﹤0.01% | 3338 |
|
|
2022
Q2 | $377K | Buy |
41,800
+30,300
| +263% | +$273K | ﹤0.01% | 3324 |
|
|
2022
Q1 | $86K | Buy |
+11,500
| New | +$86K | ﹤0.01% | 3821 |
|
|
2021
Q1 | – | Sell |
-32,445
| Closed | -$364K | – | 3362 |
|
|
2020
Q4 | $364K | Sell |
32,445
-54,822
| -63% | -$615K | ﹤0.01% | 2963 |
|
|
2020
Q3 | $817K | Sell |
87,267
-210,584
| -71% | -$1.97M | ﹤0.01% | 2611 |
|
|
2020
Q2 | $548K | Buy |
297,851
+231,950
| +352% | +$427K | ﹤0.01% | 2839 |
|
|
2020
Q1 | $109K | Sell |
65,901
-22,714
| -26% | -$37.6K | ﹤0.01% | 3210 |
|
|
2019
Q4 | $255K | Buy |
88,615
+85,365
| +2,627% | +$246K | ﹤0.01% | 3112 |
|
|
2019
Q3 | $19K | Sell |
3,250
-8,225
| -72% | -$48.1K | ﹤0.01% | 3378 |
|
|
2019
Q2 | $120K | Sell |
11,475
-5,366
| -32% | -$56.1K | ﹤0.01% | 3373 |
|
|
2019
Q1 | $296K | Buy |
16,841
+5,841
| +53% | +$103K | ﹤0.01% | 3097 |
|
|
2018
Q4 | $194K | Sell |
11,000
-6,550
| -37% | -$116K | ﹤0.01% | 3142 |
|
|
2018
Q3 | $723K | Buy |
+17,550
| New | +$723K | ﹤0.01% | 2739 |
|